Price target upside
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares Price Target Upside or Downside
KNSA price target upside based on the current price and analyst average.
Direct answer
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares's analyst target implies +25.4%.
The average target is $98.00 compared with a recorded current price of $78.15.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 13, 2026.
Get free Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $78.15
- Average price target
- $98.00
- High price target
- $108.00
- Low price target
- $87.00
- Target upside
- +25.4%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026